Ipamorelin IP5 5mg*10vials

Iparrelin IP5 5mg*10 vials is an advanced, highly efficient, and optimized growth hormone-releasing pentapeptide, an upgraded, high-concentration version of the classic growth hormone peptide product IP2. Utilizing fifth-generation molecular structure optimization technology, IP5 further enhances GHS-R1a receptor activation efficiency, molecular anti-degradation properties, and in vivo metabolic stability. It retains the core highly selective physiological pulsatile growth hormone release mechanism, without interfering with cortisol and prolactin secretion, avoiding the hormonal side effects of non-selective growth hormone secretagogues. Its high-standard 5mg concentrated formulation is perfectly suited for medium- to high-dose gradient efficacy studies, high-intensity tissue repair modeling, validation of significant body component regulation mechanisms, and preclinical experiments involving long-term high-dose intervention of the growth hormone axis. It is a high-quality, highly efficient core research raw material for endocrine metabolism and cutting-edge metabolic research.

Product Functions and Research Value

In professional laboratory studies, Iparrelin IP5 efficiently activates growth hormone-releasing peptide receptors, triggering a strong, physiological pulsatile release of endogenous growth hormone, perfectly mimicking the natural growth hormone secretion rhythm in the human body. Compared to low-dose IP2, IP5 produces stronger and more significant downstream phenotypic effects, providing more intuitive experimental data for exploring mechanisms of accelerated lean muscle protein synthesis, efficient lipolysis activation, bone remodeling, and damaged tissue repair. With its extremely high receptor specificity, IP5 eliminates interference from off-target hormones, ensuring the purity and accuracy of experimental results. It is widely applicable for in-depth research on age-related growth hormone axis dysfunction, moderate to severe body composition imbalance, bone metabolic dysfunction, muscle damage repair, and validation of the synergistic effects of high-dose complex peptides, providing highly discriminative, reproducible, and stable data support for advanced growth hormone pathway mechanism research.

Core Product Advantages

1. Advanced and Efficient Upgrade of IP5: The fifth-generation optimized molecular structure significantly improves target binding activity and molecular stability compared to IP2 and traditional iparene. While maintaining ultra-high selectivity, it exhibits stronger secretion-stimulating efficacy and more significant experimental phenotypes. 2. Pure and Highly Selective Growth Hormone Secretion Mechanism: Precisely targets the GHS-R1a pathway, inducing orderly pulsed growth hormone release without stimulating excessive secretion of cortisol and prolactin, effectively reducing experimental confounding factors and ensuring the purity of research data.

3. 5mg High-Concentration Professional Specification: An upgraded medium-to-high dose specification, solving the problem of insignificant efficacy in low-dose versions. Suitable for high-dose gradient screening, high-intensity metabolic intervention, long-term continuous modeling, and complex peptide formulation research.

4. Pharmaceutical-Grade Lyophilization Process: Employs aseptic vacuum lyophilization technology to completely lock in the inherent activity of the peptides. Each batch undergoes rigorous HPLC high-purity testing and comes with a complete official Certificate of Account (COA), with extremely low impurity content and excellent batch consistency.

5. Standard 10-Volume Aseptic Packaging: 10 vials per box, integrated aseptic packaging, suitable for long-term strategic reserves in laboratories, key endocrinology research projects in universities, advanced preclinical pharmaceutical research and development, and global bulk wholesale procurement.

Iparrelin IP5 (5mg x 10 vials) is a highly effective and optimized growth hormone-secreting pentapeptide, a high-concentration upgrade of the classic IP2 in the growth hormone peptide series. This product utilizes fifth-generation molecular structure optimization technology, further improving GHS-R1a receptor activation efficiency, molecular anti-degradation ability, and in vivo metabolic stability. It maintains the core mechanism of superselective physiological pulsed growth hormone release, without interfering with cortisol and prolactin secretion, thus avoiding the hormone contamination side effects of non-selective hormone-stimulating peptides. The 5mg high-standard concentrated formula is ideal for medium- to high-dose gradient pharmacodynamic studies, the construction of high-intensity tissue repair models, the verification of important mechanisms of in vivo component regulation, and long-term preclinical experiments involving high-dose interventions of the growth hormone axis. It is a highly efficient and high-quality core research raw material for cutting-edge endocrinology and metabolism research.

Core uses and research value of peptides: